Allergy and Immunology · Rochester, MN
NPI
1417123498
Since 2008
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
2,089 services
Medicare patients, 2024
188
Average age 72
Drug cost, 2024
$1.8M
468 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rohit D Divekar was code 95004 (test - miscellaneous), 1,550 times for 32 patients. In total Rohit D Divekar billed 2,089 services in 25 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,550 | 32 | $2.92 | $4,519 |
| 95018 Test - Miscellaneous | Office | 201 | 24 | $15.44 | $3,103 |
| 99204 Office E&M - New | Office | 30 | 30 | $129.22 | $3,877 |
| 94060 Pulmonary Function Testing | Office | 16 | 15 | $32.70 | $523 |
| 99203 Office E&M - New | Office | 15 | 15 | $90.78 | $1,362 |
| 99441 Telephone Services | Office | 12 | 12 | $41.64 | $500 |
| 95012 Pulmonary | Office | 11 | 11 | $16.02 | $176 |
| 99213 Office E&M - Established | Office | 11 | 11 | $65.67 | $722 |
By year: 2022 $22K for 2,886 services; 2023 $28K for 2,447 services; 2024 $20K for 2,089 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rohit D Divekar prescribed most often to Medicare patients was Montelukast Sodium, with 62 prescriptions and refills. In total Rohit D Divekar wrote 468 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 62 | 184 | 24 | $888 |
| Ipratropium Bromide Generic | 41 | 68 | 12 | $2,512 |
| Qvar Redihaler Beclomethasone Dipropionate | 29 | 46 | Under 11 | $11K |
| Nucala Mepolizumab | 26 | 26 | Under 11 | $96K |
| Haegarda C1 Esterase Inhibitor | 25 | 25 | Under 11 | $715K |
| Diphenhydramine Hcl Generic | 16 | 16 | Under 11 | $43.37 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 16 | 16 | Under 11 | $102K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 16 | 30 | Under 11 | $7,364 |
| Dupixent Syringe Dupilumab | 16 | 17 | Under 11 | $63K |
| Azelastine Hcl Generic | 15 | 28 | Under 11 | $517 |
| Budesonide Generic | 15 | 28 | Under 11 | $8,828 |
| Dupixent Pen Dupilumab | 14 | 14 | Under 11 | $54K |
| Advair Hfa Fluticasone Propion/Salmeterol | 13 | 29 | Under 11 | $10K |
| Cyproheptadine Hcl Generic | 13 | 17 | Under 11 | $659 |
| Ventolin Hfa Albuterol Sulfate | 12 | 14 | Under 11 | $926 |
Brand drugs: 224 claims; generic drugs: 244 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rohit D Divekar were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.